If you need more lookups,
subscriptions start at $34 USD/month.
Paul Tebbey Location
Chicago, IL, US
Paul Tebbey Work
2023 -now Chief Operating Officer @
2019 -now Member Board of Directors @
2022 -2023 Chief Operating Officer @ Elusys Therapeutics, A subsidiary of NightHawk Biosciences
2021 -2023 Senior Vice-President, Product Development and Portfolio Strategy @
2020 -2021 Vice President US Medical Affairs Biosimilars @
2017 -2020 Vice President, Oncology US Medical Affairs @
2014 -2017 Therapeutic Area Lead, Biotherapeutics and Gastroenterology, US Medical Affairs @
2009 -2014 Senior Director @
2008 -2009 Managing Director @ Kolabri Consulting, LLC
2003 -2008 Director of Marketing @
1995 -2002 Product Manager @
Paul Tebbey Education
Rochester Institute of Technology
MBA (Marketing)
East Carolina University
Ph.D. (Microbiology & Immunology)
University of the West of England
B.Sc. (Applied Biologic Sciences)
Paul Tebbey Skills
Business Analysis
Start-ups
Pharmaceutical Industry
Biotechnology
Product Launch
Immunology
Rheumatology
Product Marketing
Marketing
Vaccines
Global Marketing
Commercialization
Neurology
Dermatology
Gastroenterology
Product Management
Market Access
Biologics
Biopharmaceuticals
Product Development
Cross-functional Team Leadership
Clinical Trials
Public Speaking
Sales
Start Ups
Medicine
Microsoft Excel
Cross Functional Team Leadership
Marketing Strategy
Hospitals
Paul Tebbey Summary
Paul Tebbey, based in Chicago, IL, US, is currently a Chief Operating Officer at Direct Biologics. Paul Tebbey brings experience from previous roles at Radyus Research, Elusys Therapeutics, A subsidiary of NightHawk Biosciences, NightHawk Biosciences, Inc and Fresenius Kabi USA. Paul Tebbey holds a MBA in Marketing @ Rochester Institute of Technology. With a robust skill set that includes Business Analysis, Start-ups, Pharmaceutical Industry, Biotechnology, Product Launch and more. Paul Tebbey has 3 emails and 6 mobile phone numbers on RocketReach.
Looking for a different Paul Tebbey?
Find contact details for 700 million professionals.